CARA

Cara Therapeutics Inc

Price:

0.34

USD

Volume:

1,017,137.00

United States | Pharmaceuticals

-3,385.79 %

Upside

As of 2024-07-18, the Fair Value of Cara Therapeutics Inc (CARA) is -11.20 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.34 USD, the upside of Cara Therapeutics Inc is -3,385.79%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.34 USD

Stock Price

-11.20 USD

Fair Price

Peter Lynch's formula is:

CARA Fair Value

= Earnings Growth Rate x TTM EPS
CARA Fair Value

= 5.00 x -2.24
CARA Fair Value

= -11.20
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | -106.40 | 8.40 | -88.40 | -85.50 | -118.51 | -78.08 |

YoY growth | -43.78% | 107.89% | -1,152.38% | 3.28% | -38.61% | -224.72% |

Market Cap (mil) | 18.65 |

P/E | |

Forward P/E |

EPS | -2.24 |

Avg earnings growth rate | -224.72% |

TTM earnings | -122.53 |